Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

coagulation factor VIIa

coagulation factor VIIa
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
NovoSeven RT POWDER FOR INJECTION, INTRAVENOUS 1,000 mcg, 2,000 mcg, 5,000 mcg      


Comments:

Hemophilia Blood Factor Flow Diagram


NovoSeven is classified as restricted to use by cardiovascular surgeons, emergency department physicians, hematologists, neurologists, neurosurgeons, vascular surgeons, and trauma surgeons for any of the following situations:

  1. Emergent reversal of warfarin or oral direct factor Xa inhibitor induced serious, life-threatening bleeding in adults.
  2. For those adults on those anticoagulants requiring emergent surgery.
  3. Life-threatening bleeding unresponsive to alternative therapies.

 

Reviewed: July 29, 2008 (NOVOSEVEN RT), and 25 April 2017

Updated: September 2021

 


Last updated: Sep. 14, 2021







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.